Related references
Note: Only part of the references are listed.Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls
Michelle Barton et al.
BMC INFECTIOUS DISEASES (2014)
Prevention of Infections During Primary Immunodeficiency
Claire Aguilar et al.
CLINICAL INFECTIOUS DISEASES (2014)
Neonatal invasive fungal infection in England 2004-2010
C. Oeser et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
K. Yoshikawa et al.
INFECTION (2014)
Effect of Fluconazole Prophylaxis on Candidiasis and Mortality in Premature Infants A Randomized Clinical Trial
Daniel K. Benjamin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Neonatal candidiasis: Diagnosis, prevention, and treatment
Rachel G. Greenberg et al.
JOURNAL OF INFECTION (2014)
Neonatal sepsis: Progress towards improved outcomes
Andi L. Shane et al.
JOURNAL OF INFECTION (2014)
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
Andreas H. Groll et al.
LANCET ONCOLOGY (2014)
Guideline for Primary Antifungal Prophylaxis for Pediatric Patients With Cancer or Hematopoietic Stem Cell Transplant Recipients
Michelle Science et al.
PEDIATRIC BLOOD & CANCER (2014)
Micafungin in Premature and Non-premature Infants A Systematic Review of 9 Clinical Trials
Paolo Manzoni et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Changes in the Incidence of Candidiasis in Neonatal Intensive Care Units
Sofia Aliaga et al.
PEDIATRICS (2014)
Rare Fungal Infections in Children: An Updated Review of the Literature
Zoi Dorothea Yana et al.
CURRENT FUNGAL INFECTION REPORTS (2014)
Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective
Jodi M. Lestner et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Prebiotic supplementation in preterm neonates: Updated systematic review and meta-analysis of randomised controlled trials
Ravisha Srinivasjois et al.
CLINICAL NUTRITION (2013)
Evaluation of Efficacy of Probiotics in Prevention of Candida Colonization in a PICU-A Randomized Controlled Trial
Suresh Kumar et al.
CRITICAL CARE MEDICINE (2013)
Mucormycosis treated with posaconazole: review of 96 case reports
Joerg J. Vehreschild et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2013)
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery
Jessica Ericson et al.
EARLY HUMAN DEVELOPMENT (2013)
Antifungal therapy in children: an update
Valerio Cecinati et al.
EUROPEAN JOURNAL OF PEDIATRICS (2013)
Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants
Gamze Demirel et al.
EUROPEAN JOURNAL OF PEDIATRICS (2013)
Invasive fungal infections in newborns and current management strategies
Shilpa Hundalani et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Efficacy and Safety of Micafungin for Febrile Neutropenia in Pediatric Patients With Hematological Malignancies: A Multicenter Prospective Study
Ryoji Kobayashi et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
Neurodevelopmental Outcome of Extremely Low Birth Weight Infants with Candida Infection
Ira Adams-Chapman et al.
JOURNAL OF PEDIATRICS (2013)
Role of probiotics in prevention of Candida infection in critically ill children
Suresh Kumar et al.
MYCOSES (2013)
Safety and Pharmacokinetic Profiles of Repeated-dose Micafungin in Children and Adolescents Treated for Invasive Candidiasis
Daniel K. Benjamin et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Candida parapsilosis Is a Significant Neonatal Pathogen: A Systematic Review and Meta-analysis
Mohan Pammi et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
A prospective study of the patterns and dynamics of colonization with Candida spp. in very low birth weight neonates
Eugene Leibovitz et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Echinocandin Use in the Neonatal Intensive Care Unit
Kelly E. Caudle et al.
ANNALS OF PHARMACOTHERAPY (2012)
Anidulafungin for Neonatal Hematogenous Candida Meningoencephalitis: Identification of Candidate Regimens for Humans Using a Translational Pharmacological Approach
Peter A. Warn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection
Ronen Ben-Ami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation
Michaela Doering et al.
BMC INFECTIOUS DISEASES (2012)
Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials
M. C. Ethier et al.
BRITISH JOURNAL OF CANCER (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
W. W. Hope et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Empiric Antifungal Therapy and Outcomes in Extremely Low Birth Weight Infants with Invasive Candidiasis
Rachel G. Greenberg et al.
JOURNAL OF PEDIATRICS (2012)
Antifungal prophylaxis in pediatric hematology/oncology: New choices & new data
Christopher C. Dvorak et al.
PEDIATRIC BLOOD & CANCER (2012)
Results From a Prospective, International, Epidemiologic Study of Invasive Candidiasis in Children and Neonates
William J. Steinbach et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Bovine Lactoferrin Prevents Invasive Fungal Infections in Very Low Birth Weight Infants: A Randomized Controlled Trial
Paolo Manzoni et al.
PEDIATRICS (2012)
Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants
Cumhur Aydemir et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2011)
Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy - is there a 'right' choice?
Anna Turkova et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Antifungal prophylaxis in neonates
Paolo Manzoni et al.
EARLY HUMAN DEVELOPMENT (2011)
Invasive candidiasis in neonates and children
Emmanuel Roilides
EARLY HUMAN DEVELOPMENT (2011)
Retrospective survey on the off-label use of posaconazole in pediatric hematology patients
S. Cesaro et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Investigation of a cluster of cutaneous aspergillosis in a neonatal intensive care unit
K. A. Etienne et al.
JOURNAL OF HOSPITAL INFECTION (2011)
Invasive Fungal Infections in Pediatric Patients With Hematologic Malignancies Receiving Oral Amphotericin B Solution and Early Intravenous Administration of Fluconazole
Nobuhiro Watanabe et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)
Fluconazole Prophylaxis in Extremely Low Birth Weight Infants and Neurodevelopmental Outcomes and Quality of Life at 8 to 10 Years of Age
David A. Kaufman et al.
JOURNAL OF PEDIATRICS (2011)
Risk of Azole-Enhanced Vincristine Neurotoxicity in Pediatric Patients With Hematological Malignancies: Old Problem - New Dilemma
Zoe Dorothea Pana et al.
PEDIATRIC BLOOD & CANCER (2011)
A TWICE DAILY POSACONAZOLE DOSING ALGORITHM FOR CHILDREN WITH CHRONIC GRANULOMATOUS DISEASE
Marieke E. B. Welzen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Comparison of Fluconazole and Nystatin Oral Suspensions for Prophylaxis of Systemic Fungal Infection in Very Low Birthweight Infants
Kimon Violaris et al.
AMERICAN JOURNAL OF PERINATOLOGY (2010)
Population Pharmacokinetics of Micafungin in Neonates and Young Infants
William W. Hope et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
John R. Wingard et al.
BLOOD (2010)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Risk Factors and Predictors for Candidemia in Pediatric Intensive Care Unit Patients: Implications for Prevention
Theoklis E. Zaoutis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Update on antifungal agents for paediatric patients
A. H. Groll et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Invasive fungal infections in congenital immunodeficiencies
C. Antachopoulos
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Epidemiology of invasive fungal infections in neonates and children
W. J. Steinbach
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Challenging issues in neonatal candidiasis
David A. Kaufman
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Candidemia in children
Theoklis Zaoutis
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Posaconazole salvage treatment in paediatric patients: a multicentre survey
T. Lehrnbecher et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia
Johan A. Maertens et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
A Prospective, Multicenter Study of Caspofungin for the Treatment of Documented Candida or Aspergillus Infections in Pediatric Patients
Theoklis E. Zaoutis et al.
PEDIATRICS (2009)
Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients
Christopher C. Blyth et al.
PEDIATRICS (2009)
Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients
Ioanna Filioti et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: Implications for echinocandin therapy in neonates
William W. Hope et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis - Substudy of a randomized double-blind trial
Flavio Queiroz-Telles et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species
C. Mary Healy et al.
PEDIATRICS (2008)
Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation
Elizabeth Roman et al.
PEDIATRIC BLOOD & CANCER (2008)
A comparison of AmBisome® to amphotericin B for treatment of systemic candidiasis in very low birth weight infants
Ga Won Jeon et al.
YONSEI MEDICAL JOURNAL (2007)
Posaconazole plasma concentrations in juvenile patients with invasive fungal infection
Gopal Krishna et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Fungal colonization in the neonatal intensive care unit: Risk factors, drug susceptibility, and association with invasive fungal infections
Evangelia Farmaki et al.
AMERICAN JOURNAL OF PERINATOLOGY (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory
Mehnam Soltani et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis
David W. Denning et al.
JOURNAL OF INFECTION (2006)
Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial
O. Penack et al.
ANNALS OF ONCOLOGY (2006)
Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth
David A. Kaufman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections
DK Benjamin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies
GN Mattiuzzi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Candida endocarditis in neonates: report of five cases and review of the literature
I Levy et al.
MYCOSES (2006)
The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia
H Cetin et al.
PEDIATRICS INTERNATIONAL (2005)
Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions
DT Yu et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies:: a meta-analysis of randomised-controlled trials
KZ Vardakas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Neonatal candidiasis: prophylaxis and treatment
KF Tiffany et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight
D Kaufman et al.
JOURNAL OF PEDIATRICS (2005)
Ltraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
KA Marr et al.
BLOOD (2004)
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2004)
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2004)
Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis
CM Bendel
SEMINARS IN PERINATOLOGY (2003)
Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations
N Linder et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction - Chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome
GN Mattiuzzi et al.
CANCER (2003)
Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit
A Lupetti et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
TJ Walsh et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Fluconazole prophylaxis against fungal colonization and infection in preterm infants
D Kaufman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation:: a study of the North American Marrow Transplant Group
SN Wolff et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
